Avadel Pharmaceuticals Statistics
Total Valuation
AVDL has a market cap or net worth of $1.24 billion. The enterprise value is $1.21 billion.
Important Dates
The next estimated earnings date is Wednesday, November 6, 2024, before market open.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AVDL has 96.27 million shares outstanding. The number of shares has increased by 39.29% in one year.
Shares Outstanding | 96.27M |
Shares Change (YoY) | +39.29% |
Shares Change (QoQ) | +4.86% |
Owned by Insiders (%) | 0.77% |
Owned by Institutions (%) | 84.49% |
Float | 83.23M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 132.51 |
PS Ratio | 12.47 |
Forward PS | 5.24 |
PB Ratio | 17.68 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 12.72 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.54.
Current Ratio | 2.82 |
Quick Ratio | 2.37 |
Debt / Equity | 0.54 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -10.25 |
Financial Efficiency
Return on equity (ROE) is -99.52% and return on invested capital (ROIC) is -45.19%.
Return on Equity (ROE) | -99.52% |
Return on Assets (ROA) | -34.44% |
Return on Capital (ROIC) | -45.19% |
Revenue Per Employee | $617,851 |
Profits Per Employee | -$689,766 |
Employee Count | 154 |
Asset Turnover | 0.53 |
Inventory Turnover | 0.69 |
Taxes
Income Tax | -427,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.43% in the last 52 weeks. The beta is 1.63, so AVDL's price volatility has been higher than the market average.
Beta (5Y) | 1.63 |
52-Week Price Change | +31.43% |
50-Day Moving Average | 13.82 |
200-Day Moving Average | 15.26 |
Relative Strength Index (RSI) | 43.31 |
Average Volume (20 Days) | 609,839 |
Short Selling Information
Short Interest | 10.19M |
Short Previous Month | 10.97M |
Short % of Shares Out | 12.10% |
Short % of Float | n/a |
Short Ratio (days to cover) | 12.45 |
Income Statement
In the last 12 months, AVDL had revenue of $95.15 million and -$106.22 million in losses. Loss per share was -$1.16.
Revenue | 95.15M |
Gross Profit | 90.03M |
Operating Income | -98.79M |
Pretax Income | -106.65M |
Net Income | -106.22M |
EBITDA | -97.23M |
EBIT | -98.79M |
Loss Per Share | -$1.16 |
Full Income Statement Balance Sheet
The company has $71.38 million in cash and $37.67 million in debt, giving a net cash position of $33.72 million or $0.35 per share.
Cash & Cash Equivalents | 71.38M |
Total Debt | 37.67M |
Net Cash | 33.72M |
Net Cash Per Share | $0.35 |
Equity (Book Value) | 70.29M |
Book Value Per Share | 0.73 |
Working Capital | 81.17M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -114.15M |
Capital Expenditures | n/a |
Free Cash Flow | -114.15M |
FCF Per Share | -$1.19 |
Full Cash Flow Statement Margins
Gross margin is 94.62%, with operating and profit margins of -103.82% and -111.64%.
Gross Margin | 94.62% |
Operating Margin | -103.82% |
Pretax Margin | -112.09% |
Profit Margin | -111.64% |
EBITDA Margin | -102.19% |
EBIT Margin | -103.82% |
FCF Margin | -119.96% |
Dividends & Yields
AVDL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -39.29% |
Shareholder Yield | -39.29% |
Earnings Yield | -8.54% |
FCF Yield | -9.18% |
Dividend Details Analyst Forecast
The average price target for AVDL is $24.17, which is 87.07% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $24.17 |
Price Target Difference | 87.07% |
Analyst Consensus | Strong Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 80.18% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AVDL has an Altman Z-Score of 2.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.7 |
Piotroski F-Score | 1 |